A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer.
about
Persistent androgen receptor addiction in castration-resistant prostate cancerEvolution of ramucirumab in the treatment of cancer - A review of literatureTargeting persistent androgen receptor signaling in castration-resistant prostate cancer.Antibody therapeutics for treating prostate cancer: where are we now and what comes next?In silico prediction of B cell epitopes of the extracellular domain of insulin-like growth factor-1 receptor.A critical review on ramucirumab in the treatment of advanced urothelial cancer.Efficacy and safety of different interventions in castration resistant prostate cancer progressing after docetaxel-based chemotherapy: Bayesian network analysis of randomized controlled trials.
P2860
Q26777163-34590DC0-6366-4062-B4C0-48B52FD847EBQ28276412-65F0E6D3-044F-45A2-8582-F7CBEE7EB113Q38797560-340B6D69-EF29-4399-93C1-4AB5A8CF65FFQ39000185-C326C2AE-383A-439D-AE1D-6048F4C443BBQ41838419-749C5D4C-FFD7-4CAD-BCB8-E21BC1811724Q47787312-189E36A0-5001-4966-990C-7A1AEC4F86E1Q53700821-367077A5-10C7-4C58-939E-F4FA6757CC25
P2860
A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 June 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A randomised non-comparative p ...... ion-resistant prostate cancer.
@en
A randomised non-comparative phase II trial of cixutumumab
@nl
type
label
A randomised non-comparative p ...... ion-resistant prostate cancer.
@en
A randomised non-comparative phase II trial of cixutumumab
@nl
prefLabel
A randomised non-comparative p ...... ion-resistant prostate cancer.
@en
A randomised non-comparative phase II trial of cixutumumab
@nl
P2093
P2860
P1476
A randomised non-comparative p ...... ion-resistant prostate cancer.
@en
P2093
Adarsh Joshi
Andrew Armstrong
Anna Ferrari
Celestia S Higano
Dana Rathkopf
Jonathan D Schwartz
Maha Hussain
Rebecca R Hozak
P2860
P304
P356
10.1016/J.EJCA.2015.05.019
P577
2015-06-13T00:00:00Z